Document is current
Any future updates will be listed below
-
Authors
Ietswaart, Robert
Gyori, Benjamin M.
Bachman, John A.
Sorger, Peter K.
Churchman, L. Stirling http://orcid.org/0000-0003-3888-2574
- License Information
-
More Information
Article History
Received: 15 July 2020
Accepted: 5 January 2021
First Online: 2 February 2021
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: P.K.S. is a member of the scientific advisory board or board of directors of Merrimack Pharmaceutical, Glencoe Software, Applied Biomath and RareCyte Inc., and holds equity in these companies. In the last 5 years, the Sorger lab has received research funding from Novartis and Merck. B.M.G. and J.A.B. received consulting fees from Two Six Labs, LLC. P.K.S., B.M.G., and J.A.B. declare that none of these relationships are directly or indirectly related to the content of this article. All other authors declare that they have no competing interests.
